Tectonic Therapeutic, Inc. Income Statement

Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.05M-0.09M-0.20M-0.06M-0.16M-0.15M-0.11M
Gross Profit -0.05M-0.09M-0.20M-0.06M-0.16M-0.15M-0.11M
Operating items
Research & Development 35.09M54.97M87.24M83.11M72.19M36.97M41.36M
Selling, General & Administrative 11.15M20.84M32.99M35.73M33.25M7.68M16.65M
Other Operating Expenses 83.74M
Operating Expenses 46.24M75.81M120.23M118.84M105.43M44.65M58.02M
Operating Income -46.24M-75.81M-120.23M-118.84M-105.43M-44.65M-58.02M
EBIT -46.24M-75.81M-120.23M-118.84M-105.43M-44.65M-58.02M
Non-operating items
Non Operating Investment Income -1.63M
Interest & Investment Income 1.73M2.93M0.72M-0.22M-0.30M0.58M4.26M
Other Non Operating Income 0.40M-0.51M
Non Operating Income -0.12M2.84M0.52M-0.28M-0.46M1.82M-0.51M
Net income details
EBT -44.57M-72.97M-119.71M-119.13M-105.89M-44.22M-53.86M
Tax Provisions 0.38M
Profit After Tax -46.36M-72.97M-119.71M-119.13M-105.89M-42.82M-58.00M
Income from Non-Controlling Interests 105.89M-12.53M
Income from Continuing Operations -44.57M-72.97M-119.71M-119.13M-105.89M-44.60M-53.86M
Consolidated Net Income -44.57M-72.97M-119.71M-119.13M-105.89M-44.60M-53.86M
Income towards Parent Company -44.57M-72.97M-119.71M-119.13M-105.89M-44.60M-53.86M
Preferred Dividend Payments 2.24M
Net Income towards Common Stockholders -48.60M-72.97M-119.71M-119.13M-105.89M-42.82M-57.98M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 1.86M2.00M2.64M3.04M3.64M3.65M3.71M14.75M
EBITDA -46.36M-72.97M-119.71M-119.13M-105.43M-44.65M-58.02M